Skip to main content
Focused investors/Glenn Welling

Glenn Welling - Engaged Capital

As of Q2 2026, Glenn Welling reported 9 long-equity positions worth $322.92M in aggregate.

Copy-investor backtest

Latest quarter
-1.07%
1-year
-3.61%
3-year
-28.63%
5-year
-46.61%
3-year vs S&P 500
-101.87%
5-year vs S&P 500
-120.29%
5-year top 5
-46.06%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when Glenn Welling files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 4 of 16 rows. Rows without a quote are marked unavailable.

1HAINHAIN CELESTIAL GROUP INC54.72%Add +43.4%16,861,212$389.83MNo quoteNo quote
2UPBDRENT A CTR INC NEW15.62%-5,333,609$111.31M$20.87No quote
3APOGAPOGEE ENTERPRISES INC8.89%-1,689,332$63.33MNo quoteNo quote
4STKLSUNOPTA INC4.24%Add +27.3%8,731,907$30.21M$3.46No quote
5VYXNCR CORP NEW4.12%-1,076,463$29.38M$27.29No quote
6TIVOTIVO CORP3.30%-2,525,000$23.53MNo quoteNo quote
7DFRGDEL FRISCOS RESTAURANT GROUP2.99%-3,328,000$21.33MNo quoteNo quote
8MGLNMAGELLAN HEALTH INC2.11%Reduce -11.0%227,558$15MNo quoteNo quote
9INWKINNERWORKINGS INC1.31%-2,582,346$9.35MNo quoteNo quote
10BHEBENCHMARK ELECTRS INC1.27%Reduce -84.6%343,873$9.03M$26.25No quote
11PETXARATANA THERAPEUTICS INC1.22%Reduce -30.7%2,417,149$8.7MNo quoteNo quote
12MEDMEDIFAST INC0.20%New11,242$1.43MNo quoteNo quote
16GRPNGROUPON INC-Sold0$0No quoteNo quote
15BWBABCOCK & WILCOX ENTERPRIS I-Sold0$0No quoteNo quote
14ASTEASTEC INDS INC-Sold0$0No quoteNo quote
13ANIKANIKA THERAPEUTICS INC-Sold0$0No quoteNo quote